Rubia, Javier de la
478  results:
Search for persons X
?
2

Caplacizumab improves clinical outcomes and is well tolerat..:

Pavenski, Katerina ; Scully, Marie ; Coppo, Paul...
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  5 - p. 102512 , 2024
 
?
6

Cytomegalovirus Reactivations in Allogeneic Hematopoietic S..:

Chorão, Pedro ; Henriques, Marta ; Villalba, Marta...
Transplantation and Cellular Therapy.  30 (2024)  5 - p. 538.e1-538.e10 , 2024
 
?
7

P-034 Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA × CD..:

Costa, Luciano ; Bar, Noffar ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S52-S53 , 2023
 
?
11

T Cell-Depleted Peripheral Blood versus Unmanipulated Bone ..:

Chorão, Pedro ; Montoro, Juan ; Balaguer-Roselló, Aitana...
Transplantation and Cellular Therapy.  29 (2023)  5 - p. 322.e1-322.e5 , 2023
 
?
12

Reduced Incidence of Neurologic Complications after Allogen..:

Balaguer-Roselló, Aitana ; Gil-Perotín, Sara ; Montoro, Juan...
Transplantation and Cellular Therapy.  29 (2023)  10 - p. 610.e1-610.e12 , 2023
 
?
14

OA-20 Genomic profiling of high-risk smoldering myeloma pat..:

Medina, Alejandro ; Vázquez, Iria ; Cuenca, Isabel...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S12-S13 , 2023
 
1-15